# Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

> **NCT04481035** · PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 5 (actual)

## Conditions studied

- Neurofibromatosis 1

## Interventions

- **DRUG:** N-acetylcysteine (NAC)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04481035
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-15
- **Primary completion:** 2020-06-14
- **Final completion:** 2021-12-16
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481035, "Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04481035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*